Screening for HIV-Associated Tuberculosis Using the Xpert MTB/RIF Assay
Author Information
Author(s): Lawn Stephen D., Brooks Sophie V., Kranzer Katharina, Nicol Mark P., Whitelaw Andrew, Vogt Monica, Bekker Linda-Gail, Wood Robin
Primary Institution: University of Cape Town
Hypothesis
Can the Xpert MTB/RIF assay improve tuberculosis detection in HIV-positive patients before starting antiretroviral therapy?
Conclusion
The Xpert MTB/RIF assay increased tuberculosis case detection by 45% compared to smear microscopy in HIV-positive patients at high risk of TB.
Supporting Evidence
- Xpert MTB/RIF detected 73.3% of culture-positive TB cases.
- Smear microscopy only detected 28% of TB cases.
- Xpert MTB/RIF assay increased TB case detection by 45% compared to smear microscopy.
Takeaway
This study shows that a new test can find more cases of tuberculosis in people with HIV, helping them get treated faster.
Methodology
The study involved recruiting HIV-infected patients without a current TB diagnosis and comparing the Xpert MTB/RIF assay with other diagnostic tests.
Potential Biases
Potential bias due to the study being conducted in a specific population with high TB prevalence.
Limitations
The study was conducted in a single setting, which may limit the generalizability of the findings.
Participant Demographics
Adult HIV-infected patients in a South African township, median CD4 count of 171 cells/µl.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI, 13.9–20.7
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website